Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Flowers, Nadine ^a   Hartley, Louise ^a   Rees, Karen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UBIDECARENONE;

ALL CAUSE MORTALITY; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; DIET SUPPLEMENTATION; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 85045383942     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010405     Document Type: Article

References (37)

1. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Vol. Cat. no. PHE 82, Canberra: Australian Institute of Health and Welfare, May 2007.
2. British Heart Foundation. Cardiovascular Disease. 2012. http://www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx (accessed April 2012).
3. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. American Journal of Cardiology 2007;99(10):1409-12.
4. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, et al.Lovastatin decreases coenzyme Q levels in humans. Proceedings of the National Academy of Sciences of the United States of America 1990;87:8931-4.
5. Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 2012;221(2):311-6.
6. He F, Burnier M, MacGregor G. Nutrition in cardiovascular disease: salt in hypertension and heart failure. European Heart Journal 2011;32:3073-80.
7. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
8. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007435.pub2]
9. Hofman-Bang C, Rehnquist N, Swedberg K, Wiklund I, Astrom H. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 study group. Journal of Cardiac Failure 1995;1:101-7.
10. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circulation Research 1989;65:1-21.
11. Kato T, Yoneda S. Reduction in blood viscosity by treatment with coenzymeQ10 in patients with ischemic heart disease. International Journal of Clinical Pharmacology, Therapy and Toxicology 1990;28(3):123-6.
12. Kendler BS. Supplemental conditionally essential nutrients in cardiovascular disease therapy. Journal of Cardiovascular Nursing 2006;21(1):9-16.
13. Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacology and Therapeutics 2009;124(3):259-68.
14. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proceedings of the National Academy of Sciences of the United States of America 1985;82:4240-4.
15. Langsjoen PH. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10. International Journal of Tissue Reactions 1990;12(3):169-71.
16. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for Studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
17. Littarru GP, Ho L, Folkers K. Deficiency of coenzyme Q10 in human heart disease. Part I. International Journal for Vitamin and Nutrition Research 1972;42:291-305.
18. Mackay J, Manesh GA. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization, 2004.
19. McCarty MF. Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation?. Medical Hypotheses 1999;53(4):300-4.
20. Mohr D, Bowry VW, Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochimica et Biophysica Acta 1992;1126(3):247-54.
21. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term, multicentre randomised study. The Clinical Investigator 1993;71(8 Suppl):S134-6.
22. National Health Service. Atherosclerosis. 2010. http://www.nhs.uk/conditions/Atherosclerosis/Pages/Introduction.aspx#commentCountLink (accessed April 2012).
23. Niklowitz P, Sonnenschein A, Janetzky B, Andler W, Menke T. Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. International Journal of Biological Sciences 2007;3(4):257-62.
24. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
25. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003;18(1-4):91-100.
26. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong J-Y, et al.Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21:297-306.
27. Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. Journal of Cardiac Failure 2006;12(6):464-72.
28. Schaars CF, Stalenhoef AF. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. Current Opinion in Lipidology 2008;19:553-7.
29. Shekelle P, Morton S, Hardy ML. Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease. Evidence Report/Technology Assessment (Summary) 2003;83:1-3.
30. Siri-Tarino P, Sun Q, Hu F, Krauss R. Saturated fat, carbohydrate, and cardiovascular disease. American Journal of Clinical Nutrition 2010;91:502-9.
31. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Molecular Aspects of Medicine 1997;18 Suppl:S159-68.
32. Sterne, JAC, Egger, M, Moher, D. Addressing reporting biases. In: Higgins J PT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011.
33. Turunen M, Wehlin L, Sjoberg M, Lundahl J, Dallner G, Brismar K, et al.Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochemical and Biophysical Research Communications 2002;296:255-60.
34. van Dalen EC, Caron HN, Dickinson HO, Kremer LCM. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD003917.pub4]
35. World Health Organization. The World health report 2003: shaping the future. http://www.who.int/whr/2003/en/ (accessed April 2012).
36. World Health Organization. Cardiovascular diseases (CVDs). Fact Sheet Number 317. September 2012. http://www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed April 2012).
37. Joint WHO/FAO Expert Consultation. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. 2002. WHO technical report series; 916. http://www.who.int/dietphysicalactivity/publications/trs916/en/ (accessed April 2012).